HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST

HLB Pharmaceutical Revenue

HLB Pharmaceutical had revenue of 62.50B KRW in the quarter ending September 30, 2026, with 3.14% growth. This brings the company's total for the last twelve months to 253.85B, up 44.85% year-over-year. In the year 2025, HLB Pharmaceutical had annual revenue of 205.58B with 49.97% growth. That makes HLB Pharmaceutical the 17,934th largest company in the world by revenue and 912th in South Korea.

Revenue (ttm)
253.85B
Revenue Growth
+44.85%
P/S Ratio
0.88
Revenue / Employee
1.29B
Employees
197
Market Cap
224.02B

Revenue Chart

Revenue by Segment

  • Pharmaceutical Manufacturing - Manufacturing and Sales 153.61B 74.7%
  • Pharmaceutical Distribution 51.05B 24.8%
  • Pharmaceutical Manufacturing - Other 922.90M 0.4%
Fiscal year ended Dec 31, 2025 See the full HLB Pharmaceutical breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025205.58B68.50B49.97%
Dec 31, 2024137.08B100.98B279.73%
Dec 31, 201936.10B15.56B75.75%
Dec 31, 201820.54B4.98B32.03%
Dec 31, 201715.56B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.